Altman AD - Search Results

1

New approaches to cancer care in a COVID-19 world.

Butler J, Finley C, Norell CH, Harrison S, Bryant H, Achiam MP, Altman AD, Baxter N, Bentley J, Cohen PA, Chaudry MA, Dixon E, Farrell R, Fegan S, Hashmi S, Hogdall C, Jenkins JT, Kwon J, Mala T, McNally O, Merrett N, Nelson G, Nordin A, Park J, Porter G, Reynolds J, Schieman C, Schnack T, Spigelman A, Svendsen LB, Sykes P, Thomas R. Butler J, et al. Among authors: altman ad. Lancet Oncol. 2020 Jul;21(7):e339-e340. doi: 10.1016/S1470-2045(20)30340-5. Lancet Oncol. 2020. PMID: 32615112 Free PMC article. No abstract available.

2

Maternal age-related rates of gestational trophoblastic disease.

Altman AD, Bentley B, Murray S, Bentley JR. Altman AD, et al. Obstet Gynecol. 2008 Aug;112(2 Pt 1):244-50. doi: 10.1097/AOG.0b013e3181802186. Obstet Gynecol. 2008. PMID: 18669718

3

Vacuum assisted wound closures in gynaecologic surgery.

Altman AD, Nelson G, Nation J, Chu P, Ghatage P. Altman AD, et al. J Obstet Gynaecol Can. 2011 Oct;33(10):1031-1037. doi: 10.1016/S1701-2163(16)35052-6. J Obstet Gynaecol Can. 2011. PMID: 22014780 Review.

4

Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery.

Altman AD, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. J Obstet Gynaecol Can. 2012 Jun;34(6):558-566. doi: 10.1016/S1701-2163(16)35272-0. J Obstet Gynaecol Can. 2012. PMID: 22673172

5

Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Altman AD, Nelson GS, Chu P, Nation J, Ghatage P. Altman AD, et al. Int J Gynecol Cancer. 2012 Jul;22(6):1006-12. doi: 10.1097/IGC.0b013e31825b7de8. Int J Gynecol Cancer. 2012. PMID: 22740004 Review.

6

Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.

Altman AD, Thompson J, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. J Obstet Gynaecol Can. 2012 Jul;34(7):664-72. doi: 10.1016/s1701-2163(16)35320-8. J Obstet Gynaecol Can. 2012. PMID: 22742486

7

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.

Altman AD, Nelson GS, Ghatage P, McIntyre JB, Capper D, Chu P, Nation JG, Karnezis AN, Han G, Kalloger SE, Köbel M. Altman AD, et al. Mod Pathol. 2013 Sep;26(9):1255-63. doi: 10.1038/modpathol.2013.55. Epub 2013 Apr 5. Mod Pathol. 2013. PMID: 23558569 Free article.

8

The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.

Altman AD, Liu XQ, Nelson G, Chu P, Nation J, Ghatage P. Altman AD, et al. Int J Gynecol Cancer. 2013 Nov;23(9):1569-76. doi: 10.1097/IGC.0b013e3182a57ff6. Int J Gynecol Cancer. 2013. PMID: 24100588

9

Time to surgery and the risk of cancer progression in patients with gynaecologic cancers of the lower genital tract.

Vair B, Altman AD, Nelson G. Vair B, et al. Among authors: altman ad. J Obstet Gynaecol Can. 2015 Apr;37(4):338-44. doi: 10.1016/s1701-2163(15)30284-x. J Obstet Gynaecol Can. 2015. PMID: 26001687

10

Luteinized Thecomas ("Thecomatosis") with Sclerosing Peritonitis (LTSP): Report of 2 Cases and Review of an Enigmatic Syndrome Associated with a Peritoneal Proliferation of Specialized (vimentin+/keratin+/CD34+) Submesothelial Fibroblasts.

Altman AD, Bentley JR, Rittenberg PV, Murray SK. Altman AD, et al. J Obstet Gynaecol Can. 2016 Jan;38(1):41-50. doi: 10.1016/j.jogc.2015.10.010. J Obstet Gynaecol Can. 2016. PMID: 26872755 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page